Cargando…

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters

This report evaluated long-term changes in clinical severity and laboratory parameters in 3 adult patients with severe recalcitrant atopic dermatitis (AD) who were treated with intramuscular injections of 50 mg of autologous immunoglobulin G (IgG) twice a week for 4 weeks (autologous immunoglobulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nahm, Dong-Ho, Ahn, Areum, Kim, Myoung-Eun, Cho, Su-Mi, Park, Mi Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853515/ https://www.ncbi.nlm.nih.gov/pubmed/27126731 http://dx.doi.org/10.4168/aair.2016.8.4.375

Ejemplares similares

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: A Preliminary Report
por: Nahm, Dong-Ho, et al.
Publicado: (2014)

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
por: Nahm, Dong-Ho, et al.
Publicado: (2016)

Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial
por: Nahm, Dong-Ho, et al.
Publicado: (2020)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
por: Yayli, Savas, et al.
Publicado: (2013)

Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012)

Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity
por: Thijs, J. L., et al.
Publicado: (2016)

The ability of biomarkers to assess the severity of atopic dermatitis
por: Nakahara, Takeshi, et al.
Publicado: (2023)

Influence of Weight Loss on Severity of Atopic Dermatitis in a 20-Year-Old Female with Atopic Dermatitis
por: Son, Jee Hee, et al.
Publicado: (2018)

Intramuscular Injection of Autologous Serum in Adolescent and Adult Patients with Atopic Dermatitis: A Preliminary Randomized Clinical Trial
por: Nahm, Dong-Ho, et al.
Publicado: (2023)

Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis
por: Johnson, Brian B., et al.
Publicado: (2019)

Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis
por: Jee, Sue-Jung, et al.
Publicado: (2011)

Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response
por: Lee, Youngsoo, et al.
Publicado: (2021)

Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults
por: De Greef, Axel, et al.
Publicado: (2023)

Alternative Immunomodulatory and Disease-Modifying Treatment for Atopic Dermatitis: Autologous Total Immunoglobulin G
por: Kim, Su Min, et al.
Publicado: (2020)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Intramuscular administration of autologous total immunoglobulin G induces immunomodulatory effects on T cells in healthy human subjects: An open-labeled prospective single-arm trial
por: Kwon, Byul, et al.
Publicado: (2022)

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022)

US health care utilization and costs in adult patients with atopic dermatitis by disease severity
por: Wang, Xin, et al.
Publicado: (2022)

Differences in Genetic Variations Between Treatable and Recalcitrant Atopic Dermatitis in Korean
por: Jun, Myungsoo, et al.
Publicado: (2018)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis
por: Merola, Joseph F., et al.
Publicado: (2023)

Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series
por: Breslin, Moira E., et al.
Publicado: (2016)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
por: Su, Chia-Jui, et al.
Publicado: (2021)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Thalidomide Responsive Recalcitrant Adult-Onset Atopic Dermatitis – Repurposing an Old Drug
por: Yadav, Vidya, et al.
Publicado: (2023)

Hair Mineral Analysis in Children with Atopic Dermatitis
por: Kim, Jeong Eun, et al.
Publicado: (2017)

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
por: Lee, Dong Hun, et al.
Publicado: (2022)

Improvement of Atopic Dermatitis Severity after Reducing Indoor Air Pollutants
por: Kim, Hye One, et al.
Publicado: (2013)

No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

The impact of comorbidities on the severity of atopic dermatitis in children
por: Berce, Vojko, et al.
Publicado: (2021)

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
por: Bernardo, Diana, et al.
Publicado: (2023)

Time Trends in the Prevalence of Atopic Dermatitis in Korean Children According to Age
por: Lee, Ji Young, et al.
Publicado: (2021)

Two unusual cases of severe recalcitrant hypocalcemia due to aminoglycoside-induced hypomagnesemia
por: Varma, Tarun, et al.
Publicado: (2013)

Use of Intravenous Immunoglobulin in the Treatment of Childhood Atopic Dermatitis
por: Sohn, Myung Hyun, et al.
Publicado: (2011)

Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View
por: Nahm, Dong-Ho
Publicado: (2015)

Associations of Atopic Dermatitis With Obesity and Unmarried Status in Young Adults: Evidence for Atopic Dermatitis as a Life-Style Disorder With High Social Impact
por: Nahm, Dong-Ho
Publicado: (2016)

The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis
por: Celakovská, Jarmilă, et al.
Publicado: (2016)

Impact of environmental factors in predicting daily severity scores of atopic dermatitis
por: Hurault, Guillem, et al.
Publicado: (2021)

A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
por: Jang, Dong Hyek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkrtdigb4ie2j75hm4st1pa0g9